![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 47/26 | (2006.01) |
A61K 31/55 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 9/70 | (2006.01) |
(11) | Number of the document | 2377557 |
(13) | Kind of document | T |
(96) | European patent application number | 11173623.7 |
Date of filing the European patent application | 2005-11-22 | |
(97) | Date of publication of the European application | 2011-10-19 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
(46) | Date of publication of the claims translation | 2017-02-10 |
(30) | Number | Date | Country code |
630274 P | 2004-11-24 | US |
(72) |
Dang, Phuong Grace, US
Lawrence, Brian D., US
Balwani, Gul, US
D'Addio, Alexander D., US
|
(73) |
Meda Pharmaceuticals Inc.,
1000 Mylan Boulevard, Canonsburg PA 15317,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai |
Compositions comprising azelastine and methods of use thereof |
Payment date | Validity (years) | Amount | |
2020-11-06 | 16 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-11-22 |